These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12426786)

  • 21. [Analysis of steroids. Part 45: Analytical investigation of pipecuronium bromide (Arduan)].
    Gazdag M; Szepesi G; Mihályfi K; Kemenesné BP; Horváth P; Végh Z; Rényei M; Trischler F; Görög S
    Acta Pharm Hung; 1992 May; 62(3):88-96. PubMed ID: 1323918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A pharmacodynamic study of pipecuronium bromide (Arduan) in newborn infants, infants and children].
    Praefort L
    Cah Anesthesiol; 1990 Mar; 38(2):79-85. PubMed ID: 2163731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative neuromuscular blocking potency of pipecuronium and pancuronium.
    Youssef SA; Ramadan A; Ibrahim EI
    Dtsch Tierarztl Wochenschr; 1993 Oct; 100(10):396-8. PubMed ID: 8261906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3,16-Bisquaternary ammonium steroid derivatives as neuromuscular blocking agents: synthesis and biological evaluation.
    Hu H; Rao Z; Feng M; Wu Z; Xu J; Chen H; Liu P; Xiao Y; Hong X; Hu X; Ke X
    Steroids; 2015 Apr; 96():103-14. PubMed ID: 25637675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New russian myorelaxant vero-pipecuronium (pipecuronium bromide) used for the anesthetic management of operations on the thorax and abdomen organs].
    Buniatian AA; Vyzhigina MA; Mizikov VM; Deshko IuV; Kozhevnikov VA; Zhukova SG; Batchaev ShS
    Anesteziol Reanimatol; 2004; (5):49-52. PubMed ID: 15573726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the steroid muscle relaxant pipecurium bromide on the acetylcholinesterase activity of red blood cells in vitro.
    Simon G; Biró K; Kárpáti E; Tuba Z
    Arzneimittelforschung; 1980; 30(2a):360-3. PubMed ID: 6248079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basic principles of neuromuscular transmission.
    Martyn JA; Fagerlund MJ; Eriksson LI
    Anaesthesia; 2009 Mar; 64 Suppl 1():1-9. PubMed ID: 19222426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiration paralysing and circulatory effects of a new non-depolarizing relaxant, pipecurium bromide, in anaesthetized dogs.
    Pulay I; Alánt O; Darvas K; Weltner J; Zétény Z
    Arzneimittelforschung; 1980; 30(2a):358-60. PubMed ID: 6248078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of pipecurium bromide in rats.
    Vereczkey L; Szporny L
    Arzneimittelforschung; 1980; 30(2a):364-6. PubMed ID: 6248080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of steroids. Part 44: Analytical investigation of the intermediates of the synthesis of pipecuronium bromide (Arduan)].
    Laukó A; Horváth P; Trischler F; Görög S
    Acta Pharm Hung; 1992 May; 62(3):82-7. PubMed ID: 1323917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and neuromuscular blocking activity of 16beta-N-methylpiperazino steroidal derivatives.
    Jindal DP; Piplani P; Fajrak H; Prior C; Marshall IG
    Eur J Med Chem; 2002 Nov; 37(11):901-8. PubMed ID: 12446049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antagonism of the neuromuscular block by pipecuronium bromide during anesthesia with isoflurane. A comparative study in elderly and adult patients].
    Valeri R; Montorsi E; Gioia L; Martani C; Torri G
    Minerva Anestesiol; 1990 Sep; 56(9):899-903. PubMed ID: 2177168
    [No Abstract]   [Full Text] [Related]  

  • 33. Summary of safety tests with pipecurium bromide, a new neuromuscular blocking agent.
    Cholnoky E
    Arzneimittelforschung; 1980; 30(2a):370-4. PubMed ID: 6248082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulatory effects of pipecurium bromide during anaesthesia of patients with severe valvular and ischaemic heart diseases.
    Barankay A
    Arzneimittelforschung; 1980; 30(2a):386-9. PubMed ID: 6248086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of neuromuscular blocking drugs.
    Cammu G
    Acta Anaesthesiol Belg; 2001; 52(4):357-63. PubMed ID: 11799568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approaches to short-acting neuromuscular blocking agents: nonsymmetrical bis-tetrahydroisoquinolinium mono- and diesters.
    Dhar NC; Maehr RB; Masterson LA; Midgley JM; Stenlake JB; Wastila WB
    J Med Chem; 1996 Jan; 39(2):556-61. PubMed ID: 8558527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arduan, a new neuromuscular blocking agent.
    Fister T
    Ther Hung; 1983; 31(3):117-9. PubMed ID: 6100827
    [No Abstract]   [Full Text] [Related]  

  • 38. Oto-rhino-laryngological interventions performed in arduan relaxation.
    Zelen B
    Ther Hung; 1985; 33(4):211-3. PubMed ID: 3020731
    [No Abstract]   [Full Text] [Related]  

  • 39. Observations made during operations performed under Arduan relaxation.
    Horváth I; Illés T
    Ther Hung; 1984; 32(1):13-5. PubMed ID: 6100828
    [No Abstract]   [Full Text] [Related]  

  • 40. [A nondepolarizing muscle relaxant with rapidly developing and short-term action].
    Danilov AF; Zhabko EP
    Eksp Klin Farmakol; 1998; 61(5):18-20. PubMed ID: 9854626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.